Adalynn Harris's Colleagues at QED Therapeutics
Adalynn Harris's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Adalynn Harris's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Adalynn Harris
Adalynn Harris currently works for QED Therapeutics.
Adalynn Harris's role at QED Therapeutics is Medical Science Liaison.
Adalynn Harris's email address is ***@qedtx.com. To view Adalynn Harris's full email address, please signup to ConnectPlex.
Adalynn Harris works in the Biotechnology industry.
Adalynn Harris's colleagues at QED Therapeutics are Ray Villar, Kimberly Richards, Shugufa Afifi, Chelsea Wolfe, Dr.Meenakshi Srivastava, Jacob Mercer, Liz Bergan and others.
Adalynn Harris's phone number is 650-231-4088